Skip to main content
Shenzhen Salubris Pharmaceuticals Co., Ltd. logo

Shenzhen Salubris Pharmaceuticals Co., Ltd. — Investor Relations & Filings

Ticker · 002294 ISIN · CNE100000FW8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,658 across all filing types
Latest filing 2013-07-31 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002294

About Shenzhen Salubris Pharmaceuticals Co., Ltd.

https://www.salubris.com

Shenzhen Salubris Pharmaceuticals Co., Ltd. is a research-driven enterprise focused on the development, manufacturing, and commercialization of innovative drugs and medical devices. The company specializes in therapeutic areas including cardiovascular diseases, chronic kidney disease, and metabolic disorders. Its product portfolio features proprietary treatments such as Allisartan Isoproxil for hypertension and Clopidogrel Bisulfate for anti-platelet therapy. Salubris maintains an integrated value chain encompassing research and development, active pharmaceutical ingredient production, and finished dosage manufacturing. The firm emphasizes innovation through its dedicated R&D centers and strategic focus on biologics and small molecule drugs, aiming to provide comprehensive clinical solutions for chronic conditions.

Recent filings

Filing Released Lang Actions
关于选举职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of an employee representative supervisor (监事) at Shenzhen Xinlitai Pharmaceutical Co., Ltd. It details the election process, the candidate's qualifications, and the composition of the supervisory board. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no indication of a report being attached or published. The content focuses on management/board information, specifically about changes in the supervisory board members. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short (1001 characters), consistent with an announcement rather than a full report.
2013-07-31 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Shenzhen Xinlitai Pharmaceutical Co., Ltd. regarding the re-election of the board of directors. It details the composition of the new board, the election method, candidate recommendations, qualifications, and procedural steps for the board election. There is no financial data, earnings information, or report publication mentioned. The content focuses exclusively on board/management changes and election procedures. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 3875 characters, which is consistent with a detailed announcement rather than a full report.
2013-07-22 Chinese
关于监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and composition of the Supervisory Board (监事会) of Shenzhen Salubris Pharmaceuticals Co., Ltd. It details the procedures, candidate qualifications, and nomination process for the new Supervisory Board members. There is no financial data, earnings information, or report publication mentioned. The content focuses on governance and board-related changes, specifically the election of supervisory board members. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2013-07-22 Chinese
2012年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from Shenzhen Xinlitai Pharmaceutical Co., Ltd. regarding the implementation of the 2012 annual equity distribution plan. It details the dividend payment per 10 shares, the capital increase by stock transfer, the record date, ex-dividend date, dividend payment date, and the changes in share capital. It references the approval of the plan at the 2012 annual general meeting and provides specifics on the distribution method and shareholders entitled to the dividend. The document is focused on the dividend amount, payment dates, and share capital changes related to the equity distribution. It does not contain full financial statements or comprehensive financial performance data, nor is it a report or presentation. The content matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2013-05-02 Chinese
2013年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2013 First Quarter Report" of Shenzhen Salubris Pharmaceuticals Co., Ltd. It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow information, shareholder data, and management declarations about the accuracy of the quarterly report. The presence of comprehensive financial statements and analysis for the first quarter of 2013 clearly indicates this is a quarterly financial report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2013
2013-04-22 Chinese
2013年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2013 年第一季度报告正文" which translates to "2013 First Quarter Report". It contains detailed financial data for the first quarter of 2013, including income, net profit, cash flow, assets, shareholder information, and management statements. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length (8764 characters) and content confirm it is the actual report, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2013
2013-04-22 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.